Abstract
Cardiac toxicity is a deadly condition caused by impaired cardiac activity similar to congestive heart failure (CHF). Doxorubicin (DOX) is a potent anticancer drug having a potential of myocardial damage [ [1] Minotti G. Menna P. Salvatorelli E. Cairo G. Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004; 56: 185-229 Crossref PubMed Scopus (2860) Google Scholar ]. Doxorubicin induced experimental toxicity has been characterized by heart failure and anaemia [ [2] Noiri E. Nagano N. Negishi K. et al. Efficacy of darbepoetin in doxorubicin-induced cardiorenal injury in rats. Nephron Exp Nephrol. 2006; 104: e6-e14 Crossref PubMed Scopus (20) Google Scholar ]. In human patients, risks for the use of anthracyclines have been reported associated with cardiac death which is the most prevalent of QT prolongation that triggered Torsades de Pointes [ [3] Arbel Y. Swartzon M. Justo D. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines. Anticancer Drugs. 2007; 18: 493-498 Crossref PubMed Scopus (31) Google Scholar ]. The anaemia of CHF patient is evidently due to the excessive cytokine production [ [4] Silverberg D. Wexler D. Blum M. Wollman Y. Iaina A. The cardio-renal anaemia syndrome: does it exist?. Nephrol Dial Transplant. 2003; 18: viii7-12 PubMed Google Scholar ]. Pre-treatment with erythropoietin hormone alone protected the myocardium against DOX induced impaired cardiac function and cardiomyocyte apoptosis [ [5] Kim K.H. Oudit G.Y. Backx P.H. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway. J Pharmacol Exp Ther. 2008; 324: 160-169 Crossref PubMed Scopus (93) Google Scholar ]. Therefore, the present study was designed to investigate the effects of ramipril and darbepoetin alfa, used either alone or together, on electromechanic activity of heart in an experimental toxicity model.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.